13 results on '"Lee, Soyoung"'
Search Results
2. Inhibitory effects of orientin in mast cell-mediated allergic inflammation
- Author
-
Dhakal, Hima, Lee, Soyoung, Choi, Jin Kyeong, Kwon, Taeg Kyu, Khang, Dongwoo, and Kim, Sang-Hyun
- Published
- 2020
- Full Text
- View/download PDF
3. Perfluorooctane sulfonate exacerbates mast cell-mediated allergic inflammation by the release of histamine
- Author
-
Lee, Jun-Kyoung, Lee, Soyoung, Choi, Young-Ae, Jin, Meiling, Kim, Yeon-Yong, Kang, Byeong-Cheol, Kim, Min-Jong, Dhakal, Hima, Lee, Sang-Rae, Kim, Sun-Uk, Khang, Dongwoo, and Kim, Sang-Hyun
- Published
- 2018
- Full Text
- View/download PDF
4. IRF3 Activation in Mast Cells Promotes FcεRI-Mediated Allergic Inflammation.
- Author
-
Choi, Young-Ae, Dhakal, Hima, Lee, Soyoung, Kim, Namkyung, Lee, Byungheon, Kwon, Taeg Kyu, Khang, Dongwoo, and Kim, Sang-Hyun
- Subjects
MAST cells ,TRYPTASE ,KNOCKOUT mice ,INTERFERON regulatory factors - Abstract
(1) Background: This study aims to elucidate a novel non-transcriptional action of IRF3 in addition to its role as a transcription factor in mast cell activation and associated allergic inflammation; (2) Methods: For in vitro experiments, mouse bone-marrow-derived mast cells (mBMMCs) and a rat basophilic leukemia cell line (RBL-2H3) were used for investigating the underlying mechanism of IRF3 in mast-cell-mediated allergic inflammation. For in vivo experiments, wild-type and Irf3 knockout mice were used for evaluating IgE-mediated local and systemic anaphylaxis; (3) Results: Passive cutaneous anaphylaxis (PCA)-induced tissues showed highly increased IRF3 activity. In addition, the activation of IRF3 was observed in DNP-HSA-treated mast cells. Phosphorylated IRF3 by DNP-HSA was spatially co-localized with tryptase according to the mast cell activation process, and FcεRI-mediated signaling pathways directly regulated that activity. The alteration of IRF3 affected the production of granule contents in the mast cells and the anaphylaxis responses, including PCA- and ovalbumin-induced active systemic anaphylaxis. Furthermore, IRF3 influenced the post-translational processing of histidine decarboxylase (HDC), which is required for granule maturation; and (4) Conclusion: Through this study, we demonstrated the novel function of IRF3 as an important factor inducing mast cell activation and as an upstream molecule for HDC activity. [ABSTRACT FROM AUTHOR]
- Published
- 2023
- Full Text
- View/download PDF
5. SG-SP1 Suppresses Mast Cell-Mediated Allergic Inflammation via Inhibition of FcεRI Signaling.
- Author
-
Kim, Min-Jong, Je, In-Gyu, Song, Jaeyoung, Fei, Xiang, Lee, Soyoung, Yang, Huiseon, Kang, Wonku, Jang, Yong Hyun, Seo, Seung-Yong, and Kim, Sang-Hyun
- Subjects
ANTIALLERGIC agents ,MAST cell disease ,MAST cells ,SURFACE plasmon resonance ,GALLIC acid ,INTRACELLULAR calcium ,EPIGALLOCATECHIN gallate - Abstract
Background: As the number of allergic disease increases, studies to identify new treatments take on new urgency. Epigallocatechin gallate (EGCG), a major component of green tea, has been shown to possess a wide range of pharmacological properties, including anti-inflammation and anti-viral infection. In previous study, gallic acid (GA), a part of EGCG, has shown anti-allergic inflammatory effect. To improve on preliminary evidence that GA has allergy mitigating effect, we designed SG-SP1 based on GA, and aimed to assess the effects of SG-SP1 on mast cell-mediated allergic inflammation using various animal and in vitro models. Methods: For in vitro experiments, various types of IgE-stimulated mast cells (RBL-2H3: mast cell-like basophilic leukemia cells, and primary cultured peritoneal and bone marrow-derived mast cells) were used to determine the role of SG-SP1 (0.1–1 nM). Immunoglobulin (Ig) E-induced passive cutaneous anaphylaxis and ovalbumin-induced systemic anaphylaxis, standard animal models for immediate-type hypersensitivity were also used. Results: For in vitro , SG-SP1 reduced degranulation of mast cells by down-regulating intracellular calcium levels in a concentration-dependent manner. SG-SP1 decreased expression and secretion of inflammatory cytokines in activated mast cells. This suppressive effect was associated with inhibition of the phosphorylation of Lyn, Syk and Akt, and the nuclear translocation of nuclear factor-κB. Due to the strong inhibitory effect of SG-SP1 on Lyn, the known upstream signaling to FcεRI-dependent pathway, we confirmed the direct binding of SG-SP1 to FcεRI, a high affinity IgE receptor by surface plasmon resonance experiment. Oral administration of SG-SP1 hindered allergic symptoms of both anaphylaxis models evidenced by reduction of hypothermia, serum IgE, ear thickness, and tissue pigmentation. This inhibition was mediated by the reductions in serum histamine and interleukin-4. Conclusions: We determined that SG-SP1 directly interacts with FcεRI and propose SG-SP1 as a therapeutic candidate for mast cell-mediated allergic inflammatory disorders via inhibition of FcεRI signaling. [ABSTRACT FROM AUTHOR]
- Published
- 2020
- Full Text
- View/download PDF
6. Gomisin M2 Inhibits Mast Cell-Mediated Allergic Inflammation via Attenuation of FcεRI-Mediated Lyn and Fyn Activation and Intracellular Calcium Levels.
- Author
-
Dhakal, Hima, Lee, Soyoung, Kim, Eun-Nam, Choi, Jin Kyeong, Kim, Min-Jong, Kang, Jinjoo, Choi, Young-Ae, Baek, Moon-Chang, Lee, Byungheon, Lee, Hyun-Shik, Shin, Tae-Yong, Jeong, Gil-Saeng, and Kim, Sang-Hyun
- Subjects
INTRACELLULAR calcium ,IMMUNOGLOBULIN E ,MAST cells ,SCHISANDRA chinensis ,INFLAMMATORY mediators ,ALLERGIES - Abstract
Mast cells are effector cells that induce allergic inflammation by secreting inflammatory mediators. Gomisin M2 (G.M2) is a lignan isolated from Schisandra chinensis (Turcz). Baill. exhibiting anti-cancer activities. We aimed to investigate the anti-allergic effects and the underlying mechanism of G.M2 in mast cell–mediated allergic inflammation. For the in vitro study, we used mouse bone marrow–derived mast cells, RBL-2H3, and rat peritoneal mast cells. G.M2 inhibited mast cell degranulation upon immunoglobulin E (IgE) stimulation by suppressing the intracellular calcium. In addition, G.M2 inhibited the secretion of pro-inflammatory cytokines. These inhibitory effects were dependent on the suppression of FcεRI-mediated activation of signaling molecules. To confirm the anti-allergic effects of G.M2 in vivo , IgE-mediated passive cutaneous anaphylaxis (PCA) and ovalbumin-induced active systemic anaphylaxis (ASA) models were utilized. Oral administration of G.M2 suppressed the PCA reactions in a dose-dependent manner. In addition, G.M2 reduced the ASA reactions, including hypothermia, histamine, interleukin-4, and IgE production. In conclusion, G.M2 exhibits anti-allergic effects through suppression of the Lyn and Fyn pathways in mast cells. According to these findings, we suggest that G.M2 has potential as a therapeutic agent for the treatment of allergic inflammatory diseases via suppression of mast cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
7. Association between perfluorooctanoic acid exposure and degranulation of mast cells in allergic inflammation.
- Author
-
Lee, Jun‐Kyoung, Lee, Soyoung, Baek, Moon‐Chang, Lee, Byung‐Heon, Lee, Hyun‐Shik, Kwon, Taeg Kyu, Park, Pil‐Hoon, Shin, Tae‐Yong, Khang, Dongwoo, and Kim, Sang‐Hyun
- Subjects
ALLERGY diagnosis ,PERFLUOROOCTANOIC acid ,MAST cells ,HISTAMINE release ,CYTOKINE receptors - Abstract
Perfluorooctanoic acid (PFOA) has wide applications, including as a raw material for converted paper and packaging products. With the widespread use of PFOA, concerns regarding its potential environmental and health impacts have increased. In spite of the known hepatotoxicity and genotoxicity of PFOA, correlation with PFOA and allergic inflammation is not well known. In this study, the effect of PFOA on the degranulation of mast cells and mast cell-mediated allergic inflammation in the presence of FcεRI cross-linking was evaluated. In immunoglobulin (Ig) E-stimulated mast cells, PFOA increased the release of histamine and β-hexosaminidase by the up-regulation of intracellular calcium levels. PFOA enhanced gene expression of several pro-inflammatory cytokines, including tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 by the activation of nuclear factor (NF)-κB in IgE-stimulated mast cells. Also, PFOA exacerbated allergic symptoms via hypothermia, and an increase of serum histamine, TNF-α, IgE and IgG
1 in the ovalbumin-induced systemic anaphylaxis. The present data indicate that PFOA aggravated FcɛRI-mediated mast cell degranulation and allergic symptoms. Copyright © 2016 John Wiley & Sons, Ltd. [ABSTRACT FROM AUTHOR]- Published
- 2017
- Full Text
- View/download PDF
8. Perfluorooctanoic acid induces mast cell-mediated allergic inflammation by the release of histamine and inflammatory mediators
- Author
-
Singh, Thoudam S.K., Lee, Soyoung, Kim, Hui-Hun, Choi, Jin Kyeong, and Kim, Sang-Hyun
- Subjects
- *
PERFLUOROOCTANOIC acid , *MAST cells , *HISTAMINE , *INFLAMMATION , *INTERLEUKIN-1 , *MITOGEN-activated protein kinases - Abstract
Abstract: Perfluorooctanoic acid (PFOA) has unique physical and chemical characteristics, water and oil repellency, thermal stability, and surfactant properties. PFOA has been regularly found in the blood of animals and humans worldwide, and has become an increasing concern because of its adverse effects in immune system. However, the role of PFOA in the allergic inflammation is not well-known. To further extend the immunotoxicity of PFOA, we examined the role of PFOA on the mast cell-mediated allergic inflammation and studied the possible mechanism of action. PFOA dose- and time-dependently increased histamine release from mast cells and serum histamine by the induction of intracellular calcium. PFOA exacerbated the IgE-dependent local allergic reaction in the mouse allergy model. PFOA induced gene expression of pro-inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1β, IL-6, and IL-8 in mast cells. The inducing effect of PFOA on the pro-inflammatory cytokines was nuclear factor-κB, p38 mitogen-activated protein kinase, and caspase-1 dependent. Furthermore, the activation of cyclooxygenase-2 by PFOA suggests the induction of allergic inflammatory mediators by the PFOA. Our findings provide evidence that PFOA, the known immunotoxic agent, induces mast cell-derived allergic inflammatory reactions by histamine release and expression of pro-inflammatory cytokines. [Copyright &y& Elsevier]
- Published
- 2012
- Full Text
- View/download PDF
9. Chrysin suppresses mast cell-mediated allergic inflammation: Involvement of calcium, caspase-1 and nuclear factor-κB
- Author
-
Bae, Yunju, Lee, Soyoung, and Kim, Sang-Hyun
- Subjects
- *
FLAVONOIDS , *MAST cells , *ALLERGIES , *INFLAMMATION , *NF-kappa B , *INTRACELLULAR calcium , *LABORATORY rats , *CYTOKINES , *TUMOR necrosis factors - Abstract
Abstract: A great number of people are suffering from allergic inflammatory diseases such as asthma, atopic dermatitis, and sinusitis. Therefore discovery of drugs for the treatment of these diseases is an important subject in human health. Chrysin (5,7-dihydroxyflavone) is a natural flavonoid contained in propolis, blue passion flower, and fruits. Several studies reported that chrysin has beneficial effects including anti-tumor and anti-oxidant activities. The aim of the present study was to elucidate whether chrysin modulates the allergic inflammatory reaction and to study its possible mechanisms of action using mast cell-based in vitro and in vivo models. Chrysin inhibited immediate-type systemic hypersensitivity and serum histamine release. Chrysin attenuated immunoglobulin E-mediated local anaphylaxis. These inhibitory effects of chrysin on the systemic and local allergic reaction were more potent than cromolyn, a known anti-allergic drug. Chrysin reduced histamine release from mast cells. The inhibitory effect of chrysin on the histamine release was mediated by the modulation of intracellular calcium. In addition, chrysin decreased gene expression of pro-inflammatory cytokines such as, tumor necrosis factor-α, IL (interleukin)-1β, IL-4, and IL-6 in mast cells. The inhibitory effect of chrysin on the pro-inflammatory cytokine was nuclear factor-κB and caspase-1 dependent. Our findings provide evidence that chrysin inhibits mast cell-derived allergic inflammatory reactions by blocking histamine release and pro-inflammatory cytokine expression, and suggest the mechanisms of action. Furthermore, in vivo and in vitro anti-allergic inflammatory effect of chrysin suggests a possible therapeutic application of this agent in allergic inflammatory diseases. [Copyright &y& Elsevier]
- Published
- 2011
- Full Text
- View/download PDF
10. Nothofagin suppresses mast cell-mediated allergic inflammation.
- Author
-
Kang, Byeong-Cheol, Kim, Min-Jong, Lee, Soyoung, Choi, Young-Ae, Park, Pil-Hoon, Shin, Tae-Yong, Kwon, Taeg Kyu, Khang, Dongwoo, and Kim, Sang-Hyun
- Subjects
- *
INFLAMMATION , *DIHYDROCHALCONES , *MAST cells , *HISTAMINE , *IMMUNOGLOBULIN E , *HEXOSAMINIDASE , *ANAPHYLAXIS - Abstract
Abstract Mast cells play a major role in immunoglobulin E-mediated allergic inflammation, which is involved in asthma, atopic dermatitis, and allergic rhinitis. Nothofagin has been shown to ameliorate various inflammatory responses such as the septic response and vascular inflammation. In this study, we assessed the inhibitory effect of nothofagin on allergic inflammation using cultured/isolated mast cells and an anaphylaxis mouse model. Nothofagin treatment prevented histamine and β-hexosaminidase release by reducing the influx of calcium into the cytosol in a concentration-dependent manner. Nothofagin also inhibited the gene expression and secretion of pro-inflammatory cytokines such as tumor necrosis factor-α and interleukin-4 by downregulating the phosphorylation of Lyn, Syk, Akt and nuclear translocation of nuclear factor-κB. To confirm these effects of nothofagin in vivo , we used a passive cutaneous anaphylaxis mouse model. Topical administration of nothofagin suppressed local pigmentation and ear thickness. Taken together, these results suggest nothofagin as a potential candidate for the treatment of mast cell-involved allergic inflammatory diseases. Highlights • Nothofagin suppressed IgE-induced mast cell degranulation. • Nothofagin downregulated NF-κB translocation through blocking calcium influx. • Nothofagin attenuates vascular permeability induced by mast cell degranulation. • Nothofagin could be used to ameliorate allergic inflammation. [ABSTRACT FROM AUTHOR]
- Published
- 2019
- Full Text
- View/download PDF
11. Inhibitory effect of putranjivain A on allergic inflammation through suppression of mast cell activation.
- Author
-
Kim, Hui-Hun, Park, Seung-Bin, Lee, Soyoung, Kwon, Taeg Kyu, Shin, Tae-Yong, Park, Pil-Hoon, Lee, Seung-Ho, and Kim, Sang-Hyun
- Subjects
- *
MAST cells , *ANTIVIRAL agents , *INFLAMMATION , *ALLERGIES , *ATOPIC dermatitis treatment , *ASTHMA treatment , *ELLAGITANNINS - Abstract
Abstract: A great number of people are suffering from allergic inflammatory disease such as asthma, atopic dermatitis, and sinusitis. Therefore discovery of drugs for the treatment of these diseases is an important subject in human health. Putranjivain A (PJA), member of ellagitannin, is known to possess beneficial effects including anti-cancer and anti-viral activities. The aim of the present study was to elucidate whether PJA modulates the allergic inflammatory reaction and to study its possible mechanisms of action using mast cell-based in vitro and in vivo models. The study was performed in anaphylaxis mouse model and cultured mast cells. PJA inhibited the expression of pro-inflammatory cytokines in immunoglobulin E-stimulated mast cells. PJA reduced this expression by inhibiting nuclear factor (NF)-κB and nuclear factor of activated T cell. The oral administration of PJA reduced systemic and cutaneous anaphylaxis, the release of serum histamine, and the expression of the histamine H1 receptor. In addition, PJA attenuated the activation of mast cells. PJA inhibited the release of histamine from various types of mast cells by the suppression of intracellular calcium. The inhibitory activity of PJA on the allergic reaction was similar to that of disodium cromoglycate, a known anti-allergic drug. These results suggest that PJA can facilitate the prevention or treatment of allergic inflammatory diseases mediated by mast cells. [Copyright &y& Elsevier]
- Published
- 2014
- Full Text
- View/download PDF
12. Ursolic acid inhibits FcεRI-mediated mast cell activation and allergic inflammation.
- Author
-
Dhakal, Hima, Kim, Min-Jong, Lee, Soyoung, Choi, Young-Ae, Kim, Namkyung, Kwon, Taeg Kyu, Khang, Dongwoo, and Kim, Sang-Hyun
- Subjects
- *
MAST cells , *URSOLIC acid , *LABORATORY mice , *INTRACELLULAR calcium , *ANAPHYLAXIS - Abstract
• UA inhibited mast cell degranulation by reducing intracellular calcium level. • UA attenuated secretion of pro-inflammatory cytokines in mast cells. • These effects of UA were dependent on inhibition of FcεRI-mediated signaling. • UA suppressed the local and systemic anaphylactic reactions. • UA might be a potential candidate for the treatment of allergic diseases. Mast cells are the primary cells that play a crucial role in the allergic diseases via secretion of diverse allergic mediators. Ursolic acid (UA) is a naturally occurring anti-inflammatory triterpenoid possessing various biological properties such as immune regulation, antioxidant, and anti-fibrotic. The aim of this study was to evaluate the effects of UA in FcεRI-mediated mast cell activation and allergic inflammation. In this study, mast cells were stimulated with immunoglobulin E (IgE) and the anti-allergic effects of UA were assessed by measuring the levels of allergic mediators. In vivo effects of UA were observed by generating passive cutaneous anaphylaxis (PCA) and active systemic anaphylaxis (ASA) in mouse model. We found that UA inhibited the degranulation of mast cell by suppressing the intracellular calcium level in a concentration-dependent manner. UA inhibited the expression and the release of pro-inflammatory cytokines in mast cells. Anti-allergic effects of UA were demonstrated via suppression of FcεRI-mediated signaling molecules. In addition, UA inhibited the IgE-mediated PCA and ovalbumin-induced ASA reactions in a dose-dependent manner. Based on these findings, we suggest that UA might have potential as a therapeutic candidate for the treatment of allergic inflammatory diseases via inhibition of FcεRI-mediated mast cell activation. [ABSTRACT FROM AUTHOR]
- Published
- 2021
- Full Text
- View/download PDF
13. Inhibitory effect of 1,2,4,5-tetramethoxybenzene on mast cell-mediated allergic inflammation through suppression of IκB kinase complex.
- Author
-
Je, In-Gyu, Choi, Hyun Gyu, Kim, Hui-Hun, Lee, Soyoung, Choi, Jin Kyeong, Kim, Sung-Wan, Kim, Duk-Sil, Kwon, Taeg Kyu, Shin, Tae-Yong, Park, Pil-Hoon, Khang, Dongwoo, and Kim, Sang-Hyun
- Subjects
- *
ALLERGY treatment , *TUMOR necrosis factors , *ANISOLE , *MAST cells , *DRUG efficacy , *INFLAMMATION , *ATOPIC dermatitis , *KINASE inhibitors - Abstract
As the importance of allergic disorders such as atopic dermatitis and allergic asthma, research on potential drug candidates becomes more necessary. Mast cells play an important role as initiators of allergic responses through the release of histamine; therefore, they should be the target of pharmaceutical development for the management of allergic inflammation. In our previous study, anti-allergic effect of extracts of Amomum xanthioides was demonstrated. To further investigate improved candidates, 1,2,4,5-tetramethoxybenzene (TMB) was isolated from methanol extracts of A. xanthioides . TMB dose-dependently attenuated the degranulation of mast cells without cytotoxicity by inhibiting calcium influx. TMB decreased the expression of pro-inflammatory cytokines such as tumor necrosis factor-α and interleukin (IL)-4 at both the transcriptional and translational levels. Increased expression of these cytokines was caused by translocation of nuclear factor-κB into the nucleus, and it was hindered by suppressing activation of IκB kinase complex. To confirm the effect of TMB in vivo , the ovalbumin (OVA)-induced active systemic anaphylaxis (ASA) and IgE-mediated passive cutaneous anaphylaxis (PCA) models were used. In the ASA model, hypothermia was decreased by oral administration of TMB, which attenuated serum histamine, OVA-specific IgE, and IL-4 levels. Increased pigmentation of Evans blue was reduced by TMB in a dose-dependent manner in the PCA model. Our results suggest that TMB is a possible therapeutic candidate for allergic inflammatory diseases that acts through the inhibition of mast cell degranulation and expression of pro-inflammatory cytokines. [ABSTRACT FROM AUTHOR]
- Published
- 2015
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.